Charles River Laboratories CRL Return on equity

Return on equity at other companies

Labcorp HoldingsLH

11.7%+2.5pp

Rapid Micro BiosystemsRPID

-116.7%-620pp

Sotera HealthSHC

27.8%+22.6pp

Ginkgo BioworksDNA

-56.3%+23.1pp

Fortrea Holdings Inc.FTRE

-15.3%-7.0pp

RevvityRVTY

3.2%-0.5pp

FAQ

What is Charles River Laboratories's return on equity?

Charles River Laboratories (CRL) reported return on equity of -7.7% in Q2 2026.

What is the long-term trend for Charles River Laboratories's return on equity?

Over 4 years (2020 to 2025), Charles River Laboratories's return on equity has grown at a -31.2% compound annual growth rate (CAGR), from 19.4% to -4.4%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.